United States · Investor

Artis Ventures (AV)

Last cheque observed Sep 2026; 99 cheques on record.

Deploying nowNew fund $6.3M, Jun 2026VC firm

Pre-seedSeedSeries AAIHealthBiotech

Deploying now
73%of best year11cheques in 12 months, 99 on record
Since the last cheque60days00hrs00min00sec
Median round$26MRounds led1 of 99Sole investor10 roundsExits11 from the portfolioMostly inUnited States, 92%
Pitch Artis Ventures (AV)

Artis Ventures (AV) highlights

  1. 01

    11 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 48% of its rounds

  3. 03

    Sole investor in 10 rounds, median $25M

  4. 04

    11 exits from the portfolio

What they do

Our mission is to support visionary founders who are reimagining the systems that sustain life itself.From their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
Pre-seedSeedSeries ASeries BGrowthPre-IPO
Sectors
AIHealthBiotech
Based in
San Francisco, United States
Cold pitches
Not accepted

The record

Every round we can evidence, newest first99 appearances

  1. 2026

    10 rounds

  2. Sept
    GenHealth.aiSeries A · US$17MWith 4 others
  3. Aug
    Network BioUS · Ventureburn$50MWith 7 others
  4. Jul
    ValarianSeries A · GB · Ventureburn$50MWith 10 others
  5. Jul
    Arkenstone DefenseSeed · US · Ventureburn$35MWith 3 others
  6. Jul
    Conceivable Life SciencesVenture · US$18MWith 2 others
  7. Jun
    Siren BiotechnologyGrant · US$8.0MWith 3 others
  8. Apr
    Onto HealthSeries A · US$20MSole investor
  9. Mar
    Science CorpSeries C · US · Crunchbase News$230MWith 5 others
  10. Mar
    Tessera TherapeuticsVenture · USUndisclosedWith 3 others
  11. Mar
    Unnatural ProductsSeries B · US · Firms' own news pages$45MWith 8 others
  12. 2025

    10 rounds

  13. Dec
    Tessera TherapeuticsVenture · US$150MWith 3 others
  14. Oct
    BettaniSeries A · US$6.5MWith 4 others
  15. Sept
    Conceivable Life SciencesSeries A · US · TechStartups$50MWith 4 others
  16. Sept
    Delix TherapeuticsSeries B · US$25MWith 3 others
  17. Sept
    Glyphic BiotechnologiesSeries A · US$38MWith 3 others
  18. Sept
    AffectSeries B$26MWith 5 others
  19. May
    Valarian TechnologiesSeed · GB$7.0MWith 4 others
  20. May
    Rad AISeries C · US$8.0MWith 4 others
  21. Feb
    Network BioSeed · US$17MWith 3 others
  22. Jan
    DelfinaSeries A · US · Firms' own news pages$17MWith 5 others
  23. 2024

    8 rounds

  24. Nov
    OverT BioGrant · US$120KWith 4 others
  25. Oct
    Ozlo SleepVenture · US$12MWith 1 other
  26. Aug
    Outpace BioSeries B · US$144MWith 4 others
  27. Jun
    Eko HealthSeries D · US$41MWith 5 others
  28. Jun
    Siren BiotechnologyVenture · USUndisclosedWith 4 others
  29. May
    Rad AISeries B · US · OCV$50MWith 5 others
  30. Jan
    EnkluSeed · US$1.3MWith 3 others
  31. Jan
    Athena ClubVenture · US$34MSole investor
  32. 2023

    6 rounds

  33. Dec
    Unnatural ProductsSeries A · US$32MWith 3 others
  34. Dec
    Power Life ScienceSeries A · US$12MWith 7 others
  35. Nov
    MeomindVenture · USUndisclosedWith 2 others
  36. Jul
    Affect TherapeuticsSeries A · US$16MWith 4 others
  37. Jun
    Range BiotechnologiesSeed · US · Pillar VC$5.2MWith 4 others
  38. Jan
    CrediwatchVentureUndisclosedWith 1 other
  39. 2022

    5 rounds

  40. Oct
    Versa NetworksGrowth · US$120MWith 4 others
  41. Sept
    CURE: One app, all things healthSeries A · DE$15MWith 4 others
  42. Jul
    ReplaySeries A · US$55MSole investor
  43. Jun
    MycoMedica Life Sciences, PBCSeries A · US$60MWith 2 others
  44. May
    Locus BiosciencesSeries B · US$35MWith 4 others
  45. 2020

    4 rounds

  46. Dec
    IDbyDNADebt$10MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration3 named

RARobert Allan RiemerExecutive Officer of Artis Ventures Management III, LLC, the General PartneriFiling they signed
SLStuart L PertersonManaging Member of the General PartneriFiling they signed
SLStuart Leonardo PetersonManaging Member of Artis Ventures Management II, LLC, the General PartneriFiling they signed

We also hold 21 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$824Mgross assets of its fundsOct 2026
3+funds on filenumbered funds in its name
Exemptreporting adviserventure or small private funds
Legal name
Artis Ventures Management, L.P.
SEC number
CRD 168686

What they claim to have backed

From their own portfolio page (on their website)

1 of 1 we have independently watched raise

Artis

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Exits from the portfolio

Companies it backed that were later bought or listed11 in all

Aruba NetworksBought by Hewlett-Packard$2.7BMar 2015
TileraBought by EZChip$130MJul 2014
adBriteBought by Site ScoutUndisclosedJun 2013
InvolverBought by Oracle CorporationUndisclosedJul 2012
SchemaLogicBought by SmartlogicUndisclosedSept 2011
Force10 NetworksBought by DellUndisclosedSept 2011
VuduBought by WalmartLabs$100MFeb 2010
DashBought by BlackBerry$8.3MJun 2009
Integration AssociatesBought by Silicon Laboratories$87MJul 2008
YouTubeBought by Google$1.6BOct 2006

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Artis Ventures (AV). A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Artis Ventures (AV) put money into.

Quick answers about Artis Ventures (AV)

What does Artis Ventures (AV) invest in?

Artis Ventures (AV) invests most often at Series A and Series B (48% of the rounds on record), in sectors such as AI, Health and Biotech.

How active is Artis Ventures (AV)?

99 investments on record, 11 of them in the last 12 months, and it led 1. The most recent was in Sept 2026.

What has Artis Ventures (AV) invested in recently?

Its most recent investments on record: GenHealth.ai (Series A, Sept 2026), Network Bio (Undisclosed round, Aug 2026) and Valarian (Series A, Jul 2026).

How big are Artis Ventures (AV)'s cheques?

The median round it joins is $26M.

Does Artis Ventures (AV) lead rounds?

Sometimes: it led 1 of its 99 investments on record (1%).

Where does Artis Ventures (AV) invest?

Most of the companies it backs are in the United States (92%) and the United Kingdom (5%).

Is Artis Ventures (AV) investing now?

Yes: it is actively investing, with 11 investments in the last 12 months.

Who does Artis Ventures (AV) invest alongside?

Most often Sequoia Capital (17 rounds together), Founders Fund (12 rounds together) and Abstract Ventures (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it